Giacobbe, D R <br/><br/>
Is initial serum (1,3)-β-d-glucan truly associated with mortality in patients with candidaemia? Authors' response.  [electronic resource] 

 -  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases  Jun 2016 
 - 579 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>1469-0691 
<br/><br/><label>Standard No.: </label>10.1016/j.cmi.2016.02.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Candidemia--diagnosis<br/>Humans<br/>Prognosis<br/>Proteoglycans<br/>Serum--chemistry<br/>Survival Analysis<br/>beta-Glucans--blood